Page 35 - AN-3-1

Advanced Neurology BTKi in brain diseases

79. Yang F, Wang Z, Wei X, et al., 2014, NLRP3 deficiency neurodegeneration: lessons from the Alzheimer’s amyloid
ameliorates neurovascular damage in experimental ischemic β-peptide. Nat Rev Mol Cell Biol. 2007;8(2):101-112.
stroke. J Cereb Blood Flow Metab. 2014;34(4):660-667. doi: 10.1038/nrm2101
doi: 10.1038/jcbfm.2011.183 84. Delport A, Hewer R. The amyloid precursor protein: A
80. Franke M, Bieber M, Kraft P, Weber ANR, Stoll G, converging point in Alzheimer’s disease. Mol Neurobiol.
Schuhmann MK. The NLRP3 inflammasome drives 2022;59(7):4501-4516.
inflammation in ischemia/reperfusion injury after transient doi: 10.1007/s12035-022-02863-x
middle cerebral artery occlusion in mice. Brain Behav
Immun. 2021;92:223-233. 85. O’Brien RJ, Wong PC. Amyloid precursor protein
processing and Alzheimer’s disease. Annu Rev Neurosci.
doi: 10.1016/j.bbi.2020.12.009 2011;34:185-204.
81. Ito M, Shichita T, Okada M, et al. Bruton’s tyrosine kinase doi: 10.1146/annurev-neuro-061010-113613
is essential for NLRP3 inflammasome activation and
contributes to ischaemic brain injury. Nat Commun. 86. Nam Y, Joo B, Lee JY, et al. ALWPs improve cognitive function
2015;6:7360. and regulate aβ plaque and tau hyperphosphorylation in a
mouse model of Alzheimer’s disease. Front Mol Neurosci.
doi: 10.1038/ncomms8360 2019;12:192.
82. Jin L, Mo Y, Yue EL, Liu Y, Liu KY. Ibrutinib ameliorates doi: 10.3389/fnmol.2019.00192
cerebral ischemia/reperfusion injury through autophagy
activation and PI3K/Akt/mTOR signaling pathway in 87. Lee HJ, Jeon SG, Kim J, et al. Ibrutinib modulates Abeta/
tau pathology, neuroinflammation, and cognitive function
diabetic mice. Bioengineered. 2021;12(1):7432-7445.
in mouse models of Alzheimer’s disease. Aging Cell.
doi: 10.1080/21655979.2021.1974810 2021;20(3):e13332.
83. Haass C, Selkoe DJ. Soluble protein oligomers in doi: 10.1111/acel.13332

Volume 3 Issue 1 (2024) 11 https://doi.org/10.36922/an.2184